Skip to Main Content

Author Details

Francesco Caiazza
Department of Pharmaceutical Chemistry, University of California san francisco
1987
24
11
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36369049Accurate Identification of Mucinous Pancreatic Cystic Lesions Using Small-Volume Analytes.J Surg Res2023
36143204Current Use of Oral Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation: Results from an Italian Multicenter Prospective Study-The ISNEP Study.J Pers Med2022
35741154Translation of a Protease Turnover Assay for Clinical Discrimination of Mucinous Pancreatic Cysts.Diagnostics (Basel)2022
33094745[HCF-ANMCO/AICPR/GIEC/ITAHFA/SICOA/SICP/SIMG/SIT Cardiological Societies Council Consensus document: Anticoagulant therapy in venous thromboembolism and atrial fibrillation of the patient with cancer. Current knowledge and new evidence].G Ital Cardiol (Rome)2020
31256057The lysosomal aminopeptidase tripeptidyl peptidase 1 displays increased activity in malignant pancreatic cysts.Biol Chem2019
31404541KH-Type Splicing Regulatory Protein Controls Colorectal Cancer Cell Growth and Modulates the Tumor Microenvironment.Am J Pathol2019
29572702Depleted polymorphonuclear leukocytes in human metastatic liver reflect an altered immune microenvironment associated with recurrent metastasis.Cancer Immunol Immunother2018
29182146Immunoproteasome functions explained by divergence in cleavage specificity and regulation.Elife2017
27029880[The Italian Survey on Cardiac Rehabilitation - 2013 (ISYDE.13-Directory): national availability and organization of cardiac rehabilitation facilities].G Ital Cardiol (Rome)2016
26932782Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells.Endocr Relat Cancer2016
26702596Incidence and clinical presentation of myocardial ischemia in patients with chronic CAD in Italy: the ISPICA survey study.J Cardiovasc Med (Hagerstown)2016
25808440Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies.Biomark Med2015
25943872Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential.Clin Exp Immunol2015
26010411Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells.Br J Cancer2015
25699240Estrogen receptors and their implications in colorectal carcinogenesis.Front Oncol2015
22967992ADAM-17: a novel therapeutic target for triple negative breast cancer.Ann Oncol2013
23277062Oocyte maturation: a story of arrest and release.Front Biosci (Schol Ed)2013
21119660Cytosolic phospholipase A2-α expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours.Br J Cancer2011
20211985Cytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth.Mol Endocrinol2010
17981737Estrogen, phospholipase A and breast cancer.Front Biosci2008
17395984Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation.Endocr Relat Cancer2007
1752435817Beta-estradiol induces ERbeta up-regulation via p38/MAPK activation in colon cancer cells.Biochem Biophys Res Commun2007
3409263[Diltiazem in the acute treatment of supraventricular paroxysmal tachyarrhythmias].Cardiologia1988
3589012[Dipyridamole test and myocardial scintigraphy with Tl-201 in the diagnosis of myocardial ischemic pathology].Radiol Med1987
  • 1 - 24 of 24

Recommended Authors

Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
Dimple Chakravarty
Icahn School of Medicine at Mount Sinai
Career Start Year 2007
Number of shared co-authors 0
Bora Lim
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Rut Klinger
UCD Conway Institute, University College Dublin
Career Start Year 2006
Number of shared co-authors 0
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Jonathan Chou
University of California san francisco
Career Start Year 2005
Number of shared co-authors 0
Mandeep Kaur
Post Graduate Institute of Medical Education and Research
Career Start Year 2003
Number of shared co-authors 0
Karin Jirstr??m
Lund University
Career Start Year 2003
Number of shared co-authors 0
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 0
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
Kristiina Iljin
VTT Technical Research Centre of Finland Ltd
Career Start Year 1999
Number of shared co-authors 0
Yaqin Zhang
Jiangsu University Zhenjiang 212013
Career Start Year 1999
Number of shared co-authors 0
Cecilia Williams
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 0
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Ernst Lengyel
University of Chicago
Career Start Year 1993
Number of shared co-authors 0
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 0
John M S Bartlett
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 0
Anil K Sood
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Joan Albanell
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 0
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 0
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 0
Adrian L Harris
University of Oxford
Career Start Year 1981
Number of shared co-authors 0
Christopher C Benz
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 0
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 0
Anna DeFazio
Westmead Hospital
Career Start Year 1972
Number of shared co-authors 0

Collaborators

Charles S Craik
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 5
Anthony J O'Donoghue
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Co-authored papers 2
Matthew Ravalin
Stanford University
Co-authored papers 2
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 1
Florencia La Greca
Department of Pharmaceutical Chemistry , University of California san francisco
Co-authored papers 1
Janet L Anderl
Onyx Pharmaceuticals, Inc.
Co-authored papers 1
Giselle M Knudsen
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
Michael B Winter
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
Shirin Arastu-Kapur
Stanford University School of Medicine
Co-authored papers 1
Markus-Frederik Bohn
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 1
Peter Cimermancic
Verily Life Sciences LLC
Co-authored papers 1
Tonia J Buchholz
Onyx Pharmaceuticals, Inc.
Co-authored papers 1
Release 1.2